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Abstract 
 
Biogenic amines (BAs) are defined as low molecular weight organic bases with 
biological activity. They are formed and degraded as part of the normal metabolism of 
microorganisms, plants and animals, in which they have important physiological 
functions. In humans, BAs are involved in brain activity, the regulation of body 
temperature and stomach pH, gastric acid secretion, the immune response, and cell 
growth and differentiation etc. However, the consumption of foods with high 
concentrations of BAs can induce adverse reactions such as nausea, headaches, rashes 
and changes in blood pressure. The accumulation of BAs in the food matrix is mainly 
due to the presence of bacteria able to decarboxylate certain amino acids. The most 
common and powerful BAs found in food are histamine, tyramine and putrescine. Their 
contents vary, sometimes reaching over 2 g per kg. Histamine is the only BA for which 
maximum levels in food have been set, although general interest exists in reducing the 
presence of all BAs in all food products. This review discusses the toxic effects of BAs 
when ingested with food. 
 
Key words: biogenic amines, food products, physiology, toxicology, microbiology, 
regulation.  
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Introduction 
 
Biogenic amines (BAs) are low molecular weight organic bases with an aliphatic 
(putrescine, cadaverine, spermine, spermidine) aromatic (tyramine, phenylethylamine) 
or heterocyclic (histamine, tryptamine) structure. All are invested with biological 
activity. They are formed and degraded as part of the normal metabolism of animals, 
plants and microorganisms. Their accumulation in food products is largely due to the 
presence of microorganisms with decarboxylase activity; the removal of the alpha 
carboxyl group from an amino acid produces its corresponding BA.  
In general, the name of a BA is assigned depending on the name of the amino acid 
giving rise to it; thus, histamine is the BA formed from histidine, tyramine is that 
formed from tyramine, tryptamine is that formed from tryptophan, and 
phenylethylamine that formed from phenylalanine. However, cadaverine is synthesized 
from lysine, and putrescine is formed by the decarboxylation of ornithine or the 
decarboxylation of arginine and the subsequent deamination of the product. 
BAs play important roles in human brain activity, the regulation of body temperature 
and stomach pH, gastric acid secretion, the immune response, and cell growth and 
differentiation etc. However, an excessive oral intake of BAs can induce adverse 
reactions such as nausea, headaches, rashes and change in blood pressure. This is 
especially true in sensitive individuals and in those in whom BA detoxification is 
impaired.  
In this review, the physiological functions of BAs are examined, as are their 
toxicological effects following the ingestion of foods containing high concentrations. 
The microorganisms responsible for their synthesis are also discussed, the 
recommendable limits of BAs in foodstuffs considered, and the possibilities of detecting 
BA-producing bacteria examined. 
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Table 1. Physiological and toxicological effects of biogenic amines. 
 
BA Physiological Effects Toxicological effects 
Histamine Neurotransmitter, local hormone, 
gastric acid secretion, cell growth 
and differentiation, regulation of 
circadian rhythm, body 
temperature, food intake, learning 
and memory, immune response, 
allergic reactions 
headaches, sweating, burning nasal 
secretion, facial flushing, bright red 
rashes, dizziness, itching rashes, 
oedema (eyelids), urticaria, 
difficulty in swallowing, diarrhoea, 
respiratory distress, bronchospasm, 
increased cardiac output, 
tachycardia, extrasystoles, blood 
pressure disorders 
Tyramine Neurotransmitter,  
peripheral vasoconstriction, 
increase cardiac output, increase 
respiration, elevate blood glucose, 
release of norepinephrine 
headaches, migraine, neurological 
disorders, nausea, vomiting, 
respiratory disorders, hypertension. 
Putrescine 
 
regulation of gene expression 
maturation of intestine, cell 
growth and differentiation 
increased cardiac output, 
tachycardia, hypotension, 
carcinogenic effects 
 
Physiological role of amines  
 
BAs play a number of crucial roles in the physiology and development of eukaryotic 
cells [1, 2] their physiological role is summarized in table 1. The most active BAs are 
histamine and tyramine. Polyamines such as putrescine, spermine and spermidine also 
play essential roles in cell growth and differentiation via the regulation of gene 
expression and the modulation of signal transduction pathways.  
Histamine is present in many living tissues as a normal constituent of the body and has 
multiple effects in different mammalian and invertebrate organs [3, 4]. In humans, it is 
found in different concentrations in the brain, lung, stomach, small and large intestine, 
uterus and the ureters. It is produced and stored predominantly in mast cells, circulating 
basophiles and neurons. Histamine modulates a variety of functions by interacting with 
specific receptors on target cells, namely H1, H2 and H3, receptors of the G-protein-
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coupled receptor family. H1 receptors are found in the brain where they are involved in 
the control of the circadian rhythm, attention and cognition, and in peripheral tissues 
where they mediate vascular and bronchial muscle responses to histamine in allergic 
processes [5]. H2 receptors, although widely distributed in body tissues, seem to have a 
central role only in the regulation of acid secretion. They respond to the presence of 
histamine, provoking gastric acid secretion and the contraction of intestinal smooth 
muscle [6]. H3 receptors, originally described as presynaptic autoreceptors on brain 
histaminergic neurons that controlled histamine synthesis and release, were 
subsequently recharacterised as heteroreceptors on non-histaminergic neurons in the 
central and peripheral nervous systems. They have also been found on paracrine and 
immune cells and in smooth muscle [7, 8] where they have been associated with 
immediate and allergic hypersensitivity. When histamine binds with these receptors 
they effect the contraction of smooth muscle cells, the dilation of blood vessels and, 
therefore, an efflux of blood serum into the surrounding tissues (including the mucous 
membranes), initiating the inflammatory process [3, 6]. 
Tyramine and β-phenylethylamine are included in the group of trace amines, a family of 
endogenous compounds with strong structural similarities to classical monoamine 
neurotransmitters, although the endogenous levels of these compounds are at least two 
orders of magnitude below that of these neurotransmitters. The effects of these low 
physiological concentrations have been difficult to demonstrate, but it has been 
suggested that they serve to maintain the neuronal activity of monoamine 
neurotransmitters within defined physiological limits [9]. Interest in their functionality 
has increased in recent decades following the discovery of a new family of G-protein 
coupled receptors (GPCR), some of which are specifically activated by trace amines [9]. 
This specificity has led to the proposal of a new nomenclature for these receptors, that 
of trace amine-associated receptors (TAARs) [10]. Some of these receptors are located 
in blood vessels, which might explain the effect of tyramine on blood pressure [11]. 
Tyramine can be converted into octopamine when taken up in sympathetic nerve 
terminals, where it displaces norepinephrine (NE) from storage vesicles. A portion of 
this NE diffuses out of the nerve to react with receptors, causing hypertension and other 
sympathomimetic effects [9]. 
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The physiological role of polyamines has been related to their chemical structure. These 
molecules carry a positive charge on their primary and secondary amino groups at 
physiological pH. Thus, polyamines may act as ligands at multiple sites on DNA, RNA, 
proteins, phospholipids and nucleotide triphosphates. The biological functions of 
polyamines are mainly the regulation of gene expression by altering DNA structure and 
by modulating signal transduction pathways. The optimal functioning of the cell 
therefore requires the intracellular polyamine content be strictly controlled at the levels 
of biosynthesis, catabolism, uptake and efflux [12]. Small amounts of orally 
administrated polyamines induce cell growth; larger quantities have no effect or may 
actually inhibit growth [13]. 
The observation that polyamines play a role in the maturation of the intestine, even 
when administrated orally [14], indicates that dietary polyamines may be of importance 
in the normal development of the digestive tract. In humans in particular, these 
substances could play a role in the prevention of food allergies [15].  
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Table 2. BA content in different food products.  
BA (mg l-1 o mg kg-1)
Food  Tyramine Histamine Putrescine Cadaverine 
Phenylethyla
mine 
Spermidine Reference 
Vegetables 
Lettuce 1 - 10 - 10 16 [16] 
Spinach 8 2.0 8 - 1 23 [16] 
Potato 7 - 10 - - 10 [16] 
Zucchini (courgettes) - - 49 - 2 10 [16] 
Onion 2 - 3 - 1 4 [16] 
Tomato concentrate 10.4 4.6 25.9 5.8 - 8.4 [17] 
Ketchup 33.6 6.5 52.5 30.7 - 6.1 [17] 
Fermented soy  - 4620 12340 6340 - - [18] 
        
Fish         
Tuna Fillet Nd - Nd Nd Nd Nd [19] 
Fresh fish 61.8 23.4 - - - - [20] 
Fish for 2 day 198 209 834 233 - 4.7 [20] 
Fish sauce - 140 - - - - [21] 
Smoked mackerel - 17880 490 2520 - - [18] 
Tuna (canned) - 20000 2000 4470 - - [18] 
        
Fermented drinks        
Must 0.0 0.0 12.33 12.9 6.44 - [22] 
Wine 19 25 55 14 16.26 - [22] 
Red wine 18.2 19.6 99.9 1.0 1.4 2.64 [23] 
White wine 2.3 1.1 9.7 0.6 1.7 1.5 [23] 
Cider 4.08 6.93 12.25 - - - [24] 
Beer 3.6 3.0 7.6 1.3 - - [17] 
Beer 10.5 8.8 11.9 50.7 - - [17] 
        
Fermented meat         
Dry fermented sausages 273 57 144 81 - 18 [25] 
Sorpresa (typical Italian 
sausage) 
214 - 231 66 - 17 
[25] 
Dry-cured ham 104 114 97 64 - 16 [25] 
Dry cured belly pork 295 114 331 6 - 16 [25] 
Fresh meat 38 - - - - 19 [25] 
Chorizo (Spanish ripened 
meat sausage) 
282.38 17.5 60.4 20.1 1.2 - 
[26] 
Fuet (Spanish ripened 
sausage) 
156.9 15.2 64.7 367.2 10.1 10.3 
[23] 
Chopped pork (cooked 
meat product) 
17.6 1.4 - - - - 
[27] 
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Dairy products        
Milk    0.013 - - 0.086 [28] 
Yoghurt - ≤ 1.3 - - - - [29] 
Feta cheese  246 846 193 828 4.94 - [30] 
Terrincho cheese  216.2 15.6 217.8 349.7 - - [31] 
Raw goat’s milk cheese  324.6 43.06 86.4 196.4 27.3 - [28] 
Pasteurised goat’s milk 
cheese  
10.9 6.34 14.6 32.7 8.89 - [28] 
Blue raw milk cheese 1051 1041 875.8 756.7 27.4 - [32] 
Blue pasteurised milk 
cheese 
526.6 127 237.5 89.4 nd - [32] 
Unripened raw milk cheese 233.3 110.8 38.7 96.3 nd - [32] 
Unripened pasteurised milk 
cheese 
22 60.2 nd nd nd - [32] 
Ripened raw milk cheese 453.7 510.2 176.3 328.4 40.7 - [32] 
Ripened pasteurised milk 
cheese 
301 65.4 175.3   - [32] 
 
 
Dietary amines 
 
BAs are present in many different foods and beverages, although their concentrations 
vary widely between and even within food types. In addition, they may not be equally 
distributed within foods [33]. Although existing as endogenous components of fresh 
foods such as fruits and vegetables, BAs can accumulate as the result of uncontrolled 
microbial enzymatic activity [34]. Foods likely to contain high levels of BA included 
fish and fish products, dairy products, meat and meat products, fermented vegetables, 
soy products and alcoholic beverages such as wine and beer (Table 2). The most 
common BAs in foods are histamine, tyramine, putrescine and cadaverine (Table 2).  
The synthesis and accumulation of BA in food requires the presence of the substrate 
amino acids, bacteria with the appropriate aminoacyl decarboxylase activity, and 
environmental conditions that allow both for the necessary enzyme action and bacterial 
growth. Combinations of these factors influence the varieties and quantities of BAs 
present in foodstuffs (Table 2). Fish and certain varieties of cheese contain the highest 
amounts of histamine (up to 1000-2000 mg kg-1; Table 1) and are the foods most 
frequently associated with cases of histamine poisoning [35]. Meat, and particularly 
cheeses, have the highest concentrations of tyramine. In long-ripened cheeses made 
from raw milk, tyramine levels can reach over 1000 mg kg-1 [32] (Table 2). 
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Table 3. Producer microorganism found in foodstuffs. 
 
Food Biogenic amine Producer microorganism 
Fish Histamine Morganella morganii, Klebsiella pneumonia , Hafnia alvei, Proteus 
vulgaris, Proteus mirabilis, Enterobacter cloacae, Enterobacter 
aerogenes, Serratia fonticola, Serratia liquefaciens, Citobacter freundii, 
Clostridium sp, Pseudomonas fluorescens, Pseudomonas putida, 
Aeromonas spp., Pleisomonas shigelloides, Photobacterium spp 
Cheese Histamine Lactobacillus buchneri 
 Tryamine  Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, 
Entererocccus hirae, Lactobacillus brevis, Lactobacillus curvatus 
 Putrescine Enterobacteriaceae (Enterobacter, Serratia, Escherichia, Salmonella, 
Hafnia, Citrobacter, Klebsiella) Lactobacillus brevis  
Wine Cadaverine Enterobacteriaceae 
 Histamine Oenococcus oeni, Lactobacillus hilgardii, Pediococcus parvulus 
 Tryamine  Lactobacillus brevis, Lactobacillus hilgardii, Leuconostoc mesenteroides, 
Lactobacillus plantarum, Enterococcus faecium 
 Putrescine Lactobacillus brevis, Lactobacillus hilgardii, Leuconostoc mesenteroides, 
Lactobacillus plantarum, O. Oeni, Lb. buchneri, Lactobacillus zeae 
 Cadaverine Enterobacteriaceae 
Meat Histamine Enterobacteriaceae, Stphylococcus capitis 
 Tryamine  Staphylococccus carnosus, Staphylococccus xylosus, Staphylococccus 
epidermidis, Staphylococccus saprophyticus, Lactobacillus brevis, 
Lactobacillus curvatus, Lactobacillus sakei, Lactobacillus bavaricus, 
Carnobacterium divergens, Carnobacterium pisicola 
 Putrescine Enterobacteriaceae, M. morganii, S. liquefaciens, Pseudomonas, Lb. 
curvatus, Enterococcus 
 Cadaverine Enterobacteriaceae 
 
Biogenic amine-producing microorganisms  
 
An essential factor in the formation of BAs in foods is the presence of bacterial strains 
with the capacity to decarboxylate amino acids. This ability has been described in 
different genera, species and strains of bacteria, both Gram positive and Gram negative. 
The synthesis of BAs in bacteria may be associated with the supply of energy and to 
help protect from acid stress [36, 37]. Additional roles in DNA regulation and as free 
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radical scavengers have been suggested [38]. Fish and fish products are among the 
foods with the highest BA concentrations (mainly histamine), the product of a number 
of enteric bacteria as well as Pseudomonas (Table 3). Since BA producers are mostly 
contaminating Gram negative bacteria, many authors have suggested that BAs could be 
used as an indicator of poor quality or the following of poor manufacturing practices. In 
fermented products, however, lactic acid bacteria (LAB) are the main BA producers. 
These can be found in the raw materials, be part of the starter culture, or contaminate 
the product during its manufacture. A number of authors have suggested the ability to 
produce BAs to be a negative trait when selecting a starter, secondary or adjunct culture 
to be used in making fermented products [39, 40].  
Although Oenococcus oeni was initially considered the main bacterial species 
responsible for histamine accumulation in wine, recent studies have shown that strains 
of Lactobacillus hilgardii and Pediococcus parvulus may in fact be the culprits [41, 42].  
Tyramine is the most abundant and commonly detected BA in cheese and fermented 
meat products, in which LAB strains of Enterococcus and Lactobacillus are the main 
producers. Putrescine synthesis was initially associated with Gram negative bacteria, 
particularly members of the Enterobacteriacea [43, 44]. However, recent reports cite 
the ability of certain LAB strains of Lb. brevis isolated from wine [45] and Lb. curvatus 
and E. faecalis isolated from cheese (unpublished results) to produce putrescine by 
agmatine deamination instead of the ornithine decarboxylation pathway; their 
contribution to putrescine production in food cannot, therefore, be ruled out. In fact, 
LAB are the main bacteria responsible for putrescine production in wine [46, 42]. 
Current knowledge regarding BA-producing microorganisms varies according to the 
species or strain in question. In some cases, the genes encoding BA-producing enzymes 
(decarboxylation and transporter) have been sequenced and regulatory studies have been 
performed (for a review see 47). In others, data have been obtained after the isolation of 
the producer microorganism using decarboxylating media [48]. 
 
Toxicological effects 
 
Owing to their importance in cellular physiology, the concentrations of BAs present in 
cells and tissues are tightly regulated at the levels of biosynthesis, catabolism, uptake 
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and efflux [12]. The ingestion of foods rich in BAs could, unfortunately, alter the 
equilibrium achieved. Studies with adult rats have shown that, following ingestion, BAs 
rapidly appear in the gut, blood and a number of organs [49]. Moreover, several studies 
have highlighted toxicological effects for some BAs - even in small amounts - following 
their oral administration [14, 50, 51]. The intake of these toxic compounds can induce 
several digestive, circulatory and respiratory symptoms (Table 1).  
 
Figure 1: Fate of biogenic amines in the human intestinal tract. 
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Oxidation is the main route of BA detoxification following ingestion “Fig. (1)”, 
although methylation and acetylation have been also implicated in the detoxification of 
histamine [52, 53]. Detoxifying oxidation is carried out by specific amine oxidases 
(AOs). These enzymes are usually classified as mono- (MAO) or diamine oxidases 
(DAO) depending on the number of amino groups preferentially oxidised. MAO 
enzymes have been classified according to their inhibitors as MAO-A and MAO-B 
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enzymes. MAO-As deaminate serotonin in the central nervous system and also deal 
with dietary monoamines in the gastrointestinal system. MAO-Bs are found 
predominantly in the liver and muscle and deaminate dopamine and phenylethylamine. 
Histamine and putrescine are deaminated by a DAO in the gut, providing protection 
against the normal concentrations present in foods [54]. 
The severity of the clinical symptoms caused by BAs depends on the amount and 
variety ingested, individual susceptibility, and the level of detoxification activity in the 
gut. This activity can differ for genetic reasons and under the influence of inhibitory 
compounds (MAOIs and DAOIs). Certain antidepressants and isoflavones (and their 
metabolites) have been described to act as MAOIs. Even when taken in association with 
a trace amine-rich diet, hypertensive crises have been reported, especially in elderly 
women [54, 55, 56]. Putrescine, tyramine and β-phenylethylamine concentrations are 
also affected by MAOIs and DAOIs [57, 58]. The role of these inhibitors has been 
shown in experiments in rats and guinea pigs, in which cadaverine, putrescine and 
tyramine potentiate histamine toxicity [53, 59]. Smoking seems to be another risk factor 
that enhances the probability to suffering BA-associated symptoms; cigarette smokers 
can show a 30% reduction in their MAOA and MAOB activities [60].  
Alcohol and acetaldehyde have been described to enhance the toxic effects of BAs by 
increasing the permeability of the intestinal wall to these compounds. This effect is of 
particular importance when alcoholically-fermented beverages are contaminated with 
high concentrations of BAs, or when BA-containing foods are consumed with an 
accompanying alcoholic drink [33, 51]. 
The intake of foods with high BA loads, or the inadequate detoxification of BAs, can 
lead to their entering the systemic circulation, inducing the release of adrenaline and 
noradrenaline and provoking gastric acid secretion, an increased cardiac output, 
migraine, tachycardia, increased blood sugar levels and higher blood pressure [18]. The 
most serious and studied toxic effects of BA-rich foods have been investigated in 
patients treated with MAOIs [58, 62, 63]. Indeed, the toxic effects of some BAs were 
first discovered in patients treated with MAOIs who suffered headaches after eating 
cheese [55, 64]. Depending on the severity of the symptoms, the effects of BAs are 
described as a reaction, intolerance, or intoxication or poisoning. Reaction symptoms 
include nausea, sweating, rashes, slight variations in blood pressure and mild headache. 
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If the amount ingested is too great for efficient detoxification to be performed, or if the 
detoxification system is strongly inhibited, the symptoms become more severe (those of 
intolerance) with vomiting, diarrhoea, facial flushing, a bright red rash, bronchospasms, 
tachycardia, oral burning, hypo- or hypertension and migraine. In exceptional cases BA 
poisoning may occur, involving a hypertensive crisis (blood pressure >180/120 mmHg) 
that can lead to end-organ damage in the heart or the central nervous system [55]. 
 
Histamine 
 
Although the onset of histamine intake symptoms after eating fish (especially members 
of the scombroid family) were first recorded in sailors some centuries ago, the first 
articles that demonstrated the relationship between the histamine present and 
intoxication were published in France in 1946 [65, 66], and it was not until some 
decades later that a report linking histamine intoxication and the consumption of other 
foods (including cheese) was published [35]. 
The consumption of foods with high concentrations of histamine can cause the same 
symptoms as those seen in an allergic reaction, leading to an incorrect diagnosis (Table 
1). However, an intoxication can be distinguish from an allergy if there is no previous 
history of any such allergy, when there is an outbreak of problems involving different 
patients over a short period of time, and when the food eaten is suspected of being 
histamine-rich [35]. 
No toxicological effect is reported when food histamine levels range from 6 to 25 
mg/meal. The ingestion of 75 mg of histamine, however, is reported to cause 
intoxication symptoms in healthy people [51, 67]. The ingestion of foods with a 
histamine concentration of 400 mg kg-1 is considered dangerous to health [35], and 
certainly the intake of approximately 1000 mg of histamine is associated with severe 
intoxications [67]. An incubation period ranging from a few minutes to a few hours may 
be necessary, with symptoms usually noticeable for only a few hours [53].  
Ingested histamine first reaches the gastrointestinal tract (GIT) where, if the 
detoxification system is not able to eliminate it, it binds to specific receptors. The first 
effect of this is the contraction of the intestine’s smooth muscle and the dilation of the 
surrounding blood vessels [3]. This is followed by symptoms similar to those of an 
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allergic response (Table 1). Besides headache, gastrointestinal symptoms including 
diffuse stomach ache, colic, flatulence, and diarrhoea can occur, as well as tachycardia, 
extrasystoles, hypotension, nasal secretion, bronchospasm, oedema (eyelids) and 
urticaria [3]. High histamine concentrations and a diminished DAO activity have been 
related to a number of inflammatory and neoplastic diseases such as Crohn's disease, 
ulcerative colitis and colorectal neoplasms [4]. 
 
Tyramine 
 
The first signs of trace amines (tyramine and β-phenylethylamine) being associated with 
hypertension were discovered by a neurologist who noticed that his wife, who was 
receiving MAOI treatment, had severe headaches (caused by cerebral vasoconstriction 
followed by dilation) when eating cheese [55]. The first observation that tyramine might 
be responsible for headaches and migraines was made in 1967 [64]. This was further 
supported by studies that correlated the ingestion of tyramine-rich foodstuffs with 
migraine crises [68].  
In healthy men, an average 500 mg of orally administrated tyramine is required to 
increase the systolic blood pressure (under laboratory conditions) by at least 30 mmHg 
over that achieved by a placebo. Since women appear to be more sensitive to tyramine, 
the amount required to achieve the same effect in them might be lower [50]. In contrast, 
other authors report a concentration of over 125 mg kg-1 to be required for any effect to 
be seen in normal individuals, and indicate a concentration of 6 mg kg-1 to be 
potentially toxic when ingested in combination with MAOIs [69]. 
An excess of tyramine in the GIT (i.e., which cannot be quickly detoxified by MAOs), 
can lead to its entering the systemic circulation, in which it can reach adrenergic nerve 
terminals, be β-hydroxylated to octopamine, and stored in the vesicles with the gradual 
displacement of norepinephrine. This leads to a transient increase in blood pressure. 
Nerve stimulation results in the release of relatively small amounts of norepinephrine 
and certain amounts of octopamine, causing the functional impairment of sympathetic 
nerve transmission. This results in headaches, migraines, nausea and vomiting [70].  
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In some individuals the increase in blood pressure results in a hypertensive crisis, a rare 
but critical elevation of the blood pressure (>180/120 mmHg). This can cause end-organ 
damage to the heart or central nervous system [55].  
Apart from the systemic toxicological effects of tyramine (Table 1), this BA can also 
have an effect on the intestinal microbiota. Certainly, tyramine is known to enhance the 
adherence of the enteropathogen E. coli 1057H to epithelial cells [71]. 
Raised levels of tyramine in the brain have been associated with neurological disorders 
such as schizophrenia, Parkinson’s disease, depression and Reyes’ syndrome [9, 72]. 
Although tyramine is not able to cross the blood–brain barrier [73], its effect appears to 
be transmitted via the afferent pathway in the central vagal pre-ganglionic neurons that 
regulate the pacemaker activity of the heart [74]. 
 
Putrescine and polyamines 
 
The daily polyamine intake for an adult is estimated to vary between 350 and 550 μmol 
[75]. Thirty minutes after the intragastric administration of [14C] putrescine, 
radioactivity was detected in all segments of the gut, in the blood, and in various organs 
of adult rats [49], highlighting the potential need to control the intake of putrescine [76]. 
In addition, bacteria in the lumen of the large intestine synthesise polyamines, perhaps 
accounting for some 13% of the total [77]. These luminal polyamines of dietary and 
bacterial origin play a key role in the regulation of total polyamine homeostasis. 
Although non-direct toxic effects have been described for putrescine and other 
polyamines, their role in the regulation of cell growth, proliferation and the maturation 
of the GIT [14, 78] means the amounts present in the latter need be tightly regulated; a 
disturbed equilibrium could lead to the dysregulation of certain physiological functions 
(Table 1). Polyamines and their metabolising enzymes are tightly linked to the 
proliferation of neoplasms in the GIT, and there is increasing evidence that putrescine 
and spermidine have a role in promoting the malignant transformation of cells [78, 79]. 
Among the several biochemical alterations seen in such cells, one of the most consistent 
is the change in the intracellular polyamine content. Colorectal cancer cells have a 
higher polyamine content than the adjacent mucosa or equivalent normal tissue [80], 
highlighting the possible importance of exogenous putrescine in their development [79]. 
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Further, the transport of putrescine from the intestine to the blood is enhanced by high 
concentrations of the same [81]. In fact, it is recommended that the dietary intake of 
putrescine be reduced in patients with familial adenomatous polyposis; in a murine 
model dietary putrescine increased the malignancy grade of adenomas [82]. Elevated 
concentrations of putrescine have also been detected in gastric carcinomas caused by 
Helicobacter pylori. Putrescine levels are restored if the microbial infection is 
eliminated [83]. 
Putrescine can also interact with certain pathogenic microorganisms since it is an 
essential component in their outer structure, and has been reported related to virulence 
factors in many Gram positive and Gram negative pathogens [83]. Exogenous 
putrescine can activate the swarming phenotype needed for pathogenesis in some 
Proteus mirabilis mutants [84].  
Apart from a direct effect in promoting the transformation of cells, histamine and 
polyamines subjected to heat can give rise to secondary amines that can combine with 
nitrites, their salts generating nitrosamines of known carcinogenic, mutagenic and 
teratogenic activity [85, 86]. This is of particular importance in some fermented meat 
products to which nitrates and nitrites are added as preservatives [61]. 
 
Recommended limits of biogenic amines in food  
 
It is very difficult to establish a uniform maximum limit for ingested BAs since their 
toxic effects depend on the type of amine in question, the presence of modulating 
compounds, and by the efficiency of an individual’s detoxification mechanism. Several 
studies have also suggested that the absorption, metabolism and/or potency of one BA 
might be modified by the presence of another, which might explain why aged cheese is 
more toxic than its equivalent amount of histamine in aqueous solution [52].  
Laboratory studies on the effects of BA face a number of methodological problems. 
Most studies have focused on the effect of individual BAs administered intravenously to 
laboratory animals or healthy volunteers, but these results are difficult to transfer to 
food intake since the intravenous response is several times higher than that obtained 
with oral administrations [87]. Neither are the results of physiological response studies 
in animals always transferable to humans. In the particular case of trace amines 
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(tyramine and phenylethylamine) the type, number and distribution of the TAARs vary 
greatly among species [9]. The effects of trace amines are mainly based on clinical 
observations; no meta-analyses that might confirm their effects are therefore possible 
[88]. Ingestion limits based on case reports may be too high since, usually, only cases of 
BA poisoning are reported [35, 67]. 
Although more in-depth studies on the toxic effects of BAs are necessary, some studies 
have reported minimum toxic levels for some BAs. Wöhrl et al. [51] reported that 75 
mg of pure liquid oral histamine - a dose common in normal meals - can provoke 
immediate as well as delayed symptoms in 50% of healthy females with no history of 
food intolerance. A concentration of over 125 mg kg-1 of tyramine is considered to be 
toxic in normal individuals - almost 100 times the concentration considered potentially 
toxic when ingested in combination with MAOIs [69]. Threshold values of 100 mg kg-1 
for tyramine and 30 mg kg-1 for phenylethylamine have been suggested [89]. However, 
since there is always more than one type of BA in food, a maximum total BAs level of 
750 – 900 mg kg-1 has been proposed [89, 90 respectively]. 
Currently, the only BA for which maximum limits have been set in the EU and the USA 
is histamine. European legislation (Commission Regulation (EC) 2073/2005) limits 
histamine levels to 200 mg kg-1 in fresh fish and up to 400 mg kg-1 for cured fishery 
products. The US Food and Drug Administration considers a histamine level of ≥500 
mg kg-1 to be a danger to health. This agrees with values cited in histamine intoxication 
reports in which over 500-1000 mg kg-1 of food had been ingested [67, 91]. A 
maximum level of 2 mg l-1 of histamine has been established for alcoholic beverages in 
some countries, but only for imported products, suggesting the use of BA limits to 
protect commercial interests. 
No clear data on acceptable histamine or other BA concentrations are available for other 
foods, although concentrations of >1000 mg kg-1 are inadvisable (Table 2) [32, 67]. 
Such levels would render foods “unsafe” in terms of the legislation for histamine. 
Despite the legal vacuum with respect to other BAs, a general consensus exists 
regarding the need to reduce their concentration in food. Over recent years, a number of 
methods for the accurate determination of BA concentrations in foodstuffs have been 
developed (for a review see 92), including novel, rapid detection systems [93]. 
Designed for testing final food products, these systems could help in food quality 
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control. However, to prevent the synthesis and accumulation of BAs during the 
manufacturing processes, the technological factors that affect their content in foods 
should be taken into account [18, 46, 61, 94]. It is clear that the essential factor in the 
appearance of BA is the presence of microorganisms with decarboxylating activity. The 
development of new methods for detecting and quantifying BA producers in raw 
materials and over the manufacturing processes should enhance the quality and safety of 
food products that reach consumers [95]. The most promising in preventing BA 
accumulation are the real time quantitative PCR (RT-qPCR) methods developed for the 
early detection and quantification of BA producers in a number of food products [96, 
97, 98, 99,100]. Such tools can show when preventive measures need to be taken during 
manufacture, manipulation and storage. 
 
Conclusions  
 
BAs play essential roles in the normal development, metabolism and physiological 
functions of humans. However, when ingested in high concentrations they can cause a 
range of toxicological effects. The presence of some of these toxic compounds has been 
directly or indirectly related to a number of carcinogenic effects.  
The main source of ingested BAs are foodstuffs in which the metabolic activity - mainly 
amino acid decarboxylation - of certain microorganism causes their accumulation at 
concentrations that can pose a health risk. Most studies into the presence of BAs in 
foods have been based on the content detected in individual food types; only a few have 
looked into the real amounts of BAs that are ingested (or could be ingested) in the 
normal diet. Such studies would help provide a picture of the real dangers of BA 
ingestion; combined with a record of symptoms, this information could be used to 
establish safe BA levels. However, more double-blind, placebo-controlled clinical 
studies based on realistically ingested amounts will be needed for such levels to de 
ascertained. It should also be remembered that BAs may show synergistic effects; the 
presence of potential detoxification inhibitors and the administration pathway should 
also be taken into account. 
While more work is needed on the harmful effects of BAs, sufficient data are available 
for reasonable limits to be imposed in order to ensure the health of consumers. It would 
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be reasonable to adopt preventive ‘‘m”/ “M” limits of 200 and 500 mg of individual 
BAs per kg for foods not yet covered by legislation but which often have high 
concentrations (such as cheese). Such limits could be easily kept to by current food 
manufacturing practices and would serve as a base to be confirmed by clinical studies. 
Progress in understanding the factors involved in the accumulation of BAs and the 
development of new analytical and microbiological technologies should allow the food 
industry to keep BA concentrations below dangerous limits with no great effort. It may 
then even be possible to certify carefully manufactured products as BA-free; this would 
be of great interest to more sensitive individuals. 
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